Delivery Order SPE2DR25D2101-SPE2DR26F47EC
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.70 for OxyContin ER 20 mg tablets (100-count) on December 10, 2025, with a completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,315.52 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,423.36 for OxyContin ER 10 mg tablets (100-count units) with a completion date of December 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,293.20 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count), with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency has awarded a delivery order valued at $5,071.87 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units) with an ultimate completion date of October 30, 2025. This is a firm fixed price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement and military...
- The Defense Logistics Agency awarded a delivery order valued at $3,390.49 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) with an ultimate completion date of December 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience supplying both...
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,932.66 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count bottles) with an ultimate completion date of July 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,166.03 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with a firm fixed price and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47ECDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,175.30 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is unclassified as a set-aside and carries a firm fixed-price structure with an ultimate completion date of January 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a prominent pharmaceutical distributor serving federal agencies including the Department of Defense and Department of Veterans Affairs. The parent entity holds a separate $999,999,999.00 IDC with DLA Troop Support Medical extending through December 31, 2031. Both organizations compete on a full and open basis for federal contracts, demonstrating their capability to meet government pharmaceutical procurement requirements across multiple therapeutic domains. This particular delivery order for controlled pain management medication reflects the company's role in supplying essential pharmaceutical commodities to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/8/26 |